EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Timing of cardiac resynchronization therapy implantation

Francisco Leyva iD, Abbasin Zegard iD, Peysh Patel, Berthold Stegemann iD, Howard Marshall iD, Peter Ludman iD, Jamie Walton iD, Joseph de Bono iD, Giuseppe Boriani iD, Tian Qiu

Europace · 2023

DOI: 10.1093/europace/euad059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Francisco Leyva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aston Medical Research Institute, Aston University, Aston Triangle, Birmingham B4 7ET, UK. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Heart Failure. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medtronic, Boston Scientific, Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The optimum timing of cardiac resynchronization therapy (CRT) implantation is unknown. We explored long-term outcomes after CRT in relation to the time interval from a first heart failure hospitalization (HFH) to device implantation. Methods and results A database covering the population of England (56.3 million in 2019) was used to quantify clinical outcomes after CRT implantation in relation to first HFHs. From 2010 to 2019, 64 968 patients [age: 71.4 ± 11.7 years; 48 606 (74.8%) male] underwent CRT implantation, 57% in the absence of a previous HFH, 12.9% during the first HFH, and 30.1% after ≥1 HFH. Over 4.54 (2.80–6.71) years [median (interquartile range); 272 989 person-years], the time in years from the first HFH to CRT implantation was associated with a higher risk of total mortality [hazard ratio (HR); 95% confidence intervals (95% CI)] (1.15; 95% CI 1.14–1.16, HFH (HR: 1.26; 95% CI 1.24–1.28), and the combined endpoint of total mortality or HFH (HR: 1.19; 95% CI 1.27–1.20) than CRT in patients with no previous HFHs, after co-variate adjustment. Total mortality (HR: 1.67), HFH (HR: 2.63), and total mortality or HFH (HR: 1.92) (all P < 0.001) were highest in patients undergoing CRT ≥2 years after the first HFH.

Conclusion

In this study of a healthcare system covering an entire nation, delays from a first HFH to CRT implantation were associated with progressively worse long-term clinical outcomes. The best clinical outcomes were observed in patients with no previous HFH and in those undergoing CRT implantation during the first HFH. Condensed abstract The optimum timing of CRT implantation is unknown. In this study of 64 968 consecutive patients, delays from a first heart failure hospitalization (HFH) to CRT implantation were associated with progressively worse long-term clinical outcomes. Each year from a first HFH to CRT implantation was associated with a 21% higher risk of total mortality and a 34% higher risk of HFH. The best outcomes after CRT were observed in patients with no previous HFHs and in those undergoing implantation during their first HFH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyHeart FailureHumansMaleMiddle AgedAgedAged, 80 and overFemaleTreatment OutcomeCardiac Resynchronization Therapy DevicesEngland

Stichwörter der Autor:innen

Cardiac resynchronization therapyHeart failureHeart failure hospitalizationMortality

Autor:innen und Institutionen

  • Aston Medical Research Institute, Aston University, Aston Triangle, Birmingham B4 7ET, UK.
  • Department of Cardiology, University Hospitals Birmingham, Queen Elizabeth, Mindelsohn Way, Birmingham B15 2GW, UK.
  • Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via Università, 4, 41121, Modena, Italy.

ORCID-Profile: Francisco Leyva, Abbasin Zegard, Berthold Stegemann, Howard Marshall, Peter Ludman, Jamie Walton, Joseph de Bono, Giuseppe Boriani

Förderung

  • Medtronic
  • Boston Scientific
  • Abbott
  • Biotronik, and Microport

Zitieren

APA

Leyva, F., Zegard, A., Patel, P., Stegemann, B., Marshall, H., Ludman, P., Walton, J., de Bono, J., Boriani, G., & Qiu, T. (2023). Timing of cardiac resynchronization therapy implantation. Europace. https://doi.org/10.1093/europace/euad059

Vancouver

Leyva F, Zegard A, Patel P, Stegemann B, Marshall H, Ludman P, et al. Timing of cardiac resynchronization therapy implantation. Europace. 2023. doi:10.1093/europace/euad059

BibTeX
@article{Leyva2023,
  author = {Leyva, Francisco and Zegard, Abbasin and Patel, Peysh and Stegemann, Berthold and Marshall, Howard and Ludman, Peter and Walton, Jamie and de Bono, Joseph and Boriani, Giuseppe and Qiu, Tian},
  title = {Timing of cardiac resynchronization therapy implantation},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad059}
}
Kostenlos starten →